Lifestyle and Medication Adherence in Adults with Type 2 Diabetes in Trujillo Peru
DOI:
https://doi.org/10.64716/4070ws65Palabras clave:
Diabetes Mellitus, Type 2, Life Style; Medication Adherence, Cross-Sectional Studies, PeruResumen
Background: Sustained diabetes care requires attention to everyday health behaviors and medication use. Objective: To evaluate the association between lifestyle and medication adherence in adults with type 2 diabetes attending a hospital in Trujillo, Peru. Methods: An analytical cross-sectional study included 208 adults who had received treatment for more than six months. Lifestyle was assessed using the 25-item IMEVID questionnaire, and medication adherence was classified as high, moderate, or low using the four-item Morisky–Green questionnaire. Categorical associations were assessed using Pearson’s chi-square test; conditional Monte Carlo tests supplemented sociodemographic comparisons with sparse categories. Results: Overall, 116 participants (55.8%) were older than 60 years and 131 (63.0%) were female. Lifestyle was classified as inadequate in 167 participants (80.3%) and adequate in 41 (19.7%). Medication adherence was high in 30 (14.4%), moderate in 74 (35.6%), and low in 104 (50.0%). Lifestyle category was associated with adherence category (p < 0.001). Associations with educational level, age group, and gender were not statistically significant (Pearson p = 0.380, 0.684, and 0.794, respectively), consistent with the conditional analyses. Conclusions: Inadequate lifestyle and low medication adherence were frequent in this hospital population. Their assessment should be integrated into diabetes follow-up, while the cross-sectional findings should not be interpreted as evidence that changing lifestyle causes improved adherence.
Descargas
Referencias
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-234. https://doi.org/10.1016/s0140-6736(23)01301-6 DOI: https://doi.org/10.1016/S0140-6736(23)01301-6
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-2093. https://doi.org/10.1016/s0140-6736(24)02317-1 DOI: https://doi.org/10.1016/S0140-6736(24)02317-1
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925-1966. https://doi.org/10.1007/s00125-022-05787-2 DOI: https://doi.org/10.1007/s00125-022-05787-2
American Diabetes Association Professional Practice Committee for Diabetes. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S89-S131. https://doi.org/10.2337/dc26-s005 DOI: https://doi.org/10.2337/dc26-S005
Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, et al. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353-368. https://doi.org/10.1249/mss.0000000000002800 DOI: https://doi.org/10.1249/MSS.0000000000002800
Boonpattharatthiti K, Songkla PN, Chantara J, Koomsri C, Krass I, Chaiyakunapruk N, et al. Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis. J Diabetes Investig. 2024;15(11):1614-1625. https://doi.org/10.1111/jdi.14285 DOI: https://doi.org/10.1111/jdi.14285
Boonpattharatthiti K, Saensook T, Neelapaijit N, Sakunrag I, Krass I, Dhippayom T. The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm. 2024;20(3):255-295. https://doi.org/10.1016/j.sapharm.2023.11.009 DOI: https://doi.org/10.1016/j.sapharm.2023.11.009
Highton PJ, Funnell MP, Gupta P, Zaccardi F, Lim LL, Seidu S, et al. Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes. Diabetologia. 2026;69(3):541-556. https://doi.org/10.1007/s00125-025-06617-x DOI: https://doi.org/10.1007/s00125-025-06617-x
Calderon-Ramirez PM, Huamani-Merma E, Mirano-Ortiz-de-Orue MG, Fernandez-Guzman D, Toro-Huamanchumo CJ. Factors associated with poor adherence to medication in patients with diabetes and hypertension in Peru: findings from a pooled analysis of six years of population-based surveys. Public Health. 2024;231:108-115. https://doi.org/10.1016/j.puhe.2024.03.012 DOI: https://doi.org/10.1016/j.puhe.2024.03.012
Acevedo PK, Lord KE, Williams KN, Underhill LJ, Cordova-Ascona L, Campos K, et al. Medication adherence among people living with hypertension and diabetes in Puno, Peru: A secondary analysis of formative data of the ANDES trial. J Multimorb Comorb. 2024;14:26335565241292325. https://doi.org/10.1177/26335565241292325 DOI: https://doi.org/10.1177/26335565241292325
Alharbi S, Alhofaian A, Alaamri MM. Illness Perception and Medication Adherence among Adult Patients with Type 2 Diabetes Mellitus: A Scoping Review. Clin Pract. 2023;13(1):71-83. https://doi.org/10.3390/clinpract13010007 DOI: https://doi.org/10.3390/clinpract13010007
Alharbi S, Alhofaian A, Alaamri MM. Correlation between Illness Perception and Medication Adherence among Adult Patients with Type 2 Diabetes Mellitus in Saudi Arabia. Saudi J Med Med Sci. 2024;12(3):244-251. https://doi.org/10.4103/sjmms.sjmms_511_23 DOI: https://doi.org/10.4103/sjmms.sjmms_511_23
Parmar J, El Masri A, MacMillan F, McCaffery K, Arora A. Health literacy and medication adherence in adults from ethnic minority backgrounds with Type 2 Diabetes Mellitus: a systematic review. BMC Public Health. 2025;25(1):222. https://doi.org/10.1186/s12889-024-20734-z DOI: https://doi.org/10.1186/s12889-024-20734-z
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https://doi.org/10.1371/journal.pmed.0040296 DOI: https://doi.org/10.1371/journal.pmed.0040296
López-Carmona JM, Ariza-Andraca CR, Rodríguez-Moctezuma JR, Munguía-Miranda C. Construcción y validación inicial de un instrumento para medir el estilo de vida en pacientes con diabetes mellitus tipo 2. Salud Publica Mex. 2003;45(4):259-268. https://pubmed.ncbi.nlm.nih.gov/12974043/ DOI: https://doi.org/10.1590/S0036-36342003000400004
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. https://doi.org/10.1097/00005650-198601000-00007 DOI: https://doi.org/10.1097/00005650-198601000-00007
Velázquez-López L, Segura Cid Del Prado P, Colín-Ramírez E, Muñoz-Torres AV, Escobedo-de la Peña J. Adherence to non-pharmacological treatment is associated with the goals of cardiovascular control and better eating habits in Mexican patients with type 2 diabetes mellitus. Clin Investig Arterioscler. 2022;34(2):88-96. https://doi.org/10.1016/j.arteri.2021.03.005 DOI: https://doi.org/10.1016/j.artere.2022.03.002
Ernawati U, Wihastuti TA, Utami YW. Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review. J Public Health Res. 2021;10(2):2240. https://doi.org/10.4081/jphr.2021.2240 DOI: https://doi.org/10.4081/jphr.2021.2240
Wang M, Lee K, Thew HZ, Sowtali SN, Jiang Q, Cao Y, et al. Medication Adherence Interventions Among People Living with Diabetes: A Systematic Review. Patient Prefer Adherence. 2025;19:3095-3112. https://doi.org/10.2147/ppa.s544443 DOI: https://doi.org/10.2147/PPA.S544443
Zamanillo-Campos R, Fiol-deRoque MA, Serrano-Ripoll MJ, Llobera-Canaves J, Taltavull-Aparicio JM, Leiva-Rus A, et al. Impact of an SMS intervention to support type 2 diabetes self-management: DiabeText clinical trial. Br J Gen Pract. 2025;75(756):e457-e465. https://doi.org/10.3399/bjgp.2024.0206 DOI: https://doi.org/10.3399/BJGP.2024.0206
Dong C, Liu R, Huang Z, Yang Y, Sun S, Li R. Effect of exercise interventions based on family management or self-management on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2023;15(1):232. https://doi.org/10.1186/s13098-023-01209-4 DOI: https://doi.org/10.1186/s13098-023-01209-4
Descargas
Publicado
Declaración de disponibilidad de datos
The participant-level data are not publicly available because they contain confidential health information. Requests for access to de-identified data may be addressed to the corresponding author and will be considered on reasonable scientific grounds, subject to institutional authorization and applicable confidentiality requirements.
Número
Sección
Licencia
Derechos de autor 2026 Annel Eliane Renteria-Trujillo (Autor/a)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores conservan los derechos de autor y conceden a TUMI Health Sciences Research el derecho de primera publicación. Los artículos se publican bajo la Licencia Internacional Creative Commons Atribución 4.0 (CC BY 4.0).
